Skip to content

Bluejay Diagnostics, Inc.

BJDX

CIK 0001704287

← back to feed
Revenue (TTM)
$249.04K
Q1 May 2026
Net Income (TTM)
−$7.34M
+11.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$17.83
+96.7% YoY Q1 May 2026
Gross Margin
19.6%
Q1 May 2026
Operating Margin
-2,983.5%
Q1 May 2026
Net Margin
-2,946.5%
Q1 May 2026
Free Cash Flow (TTM)
−$8.45M
Q1 May 2026
Cash
$3.68M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
1.03M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings